1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Spondylitis Global Clinical Trials Review, H2, 2014

Spondylitis Global Clinical Trials Review, H2, 2014

  • October 2014
  • -
  • Global Data
  • -
  • 60 pages

Spondylitis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Spondylitis Global Clinical Trials Review, H2, 2014" provides data on the Spondylitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spondylitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spondylitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Spondylitis Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 5
Spondylitis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Spondylitis to Immunology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Spondylitis to Immunology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Spondylitis 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Spondylitis Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Schering-Plough Corporation (Inactive) 30
Clinical Trial Overview of Schering-Plough Corporation (Inactive) 30
NuCel, LLC 31
Clinical Trial Overview of NuCel, LLC 31
Khorakiwala Holdings and Investments Private Limited 32
Clinical Trial Overview of Khorakiwala Holdings and Investments Private Limited 32
Hetero Drugs Limited 33
Clinical Trial Overview of Hetero Drugs Limited 33
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
Clinical Trial Overview of Top Institutes / Government 35
National Institute of Arthritis and Musculoskeletal and Skin Diseases 35
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 35
Central Council for Research in Homoeopathy 36
Clinical Trial Overview of Central Council for Research in Homoeopathy 36
Turku University Hospital 37
Clinical Trial Overview of Turku University Hospital 37
Singapore General Hospital 38
Clinical Trial Overview of Singapore General Hospital 38
Rehazentrum Bad Eilsen 39
Clinical Trial Overview of Rehazentrum Bad Eilsen 39
Manipal University 40
Clinical Trial Overview of Manipal University 40
University of Sao Paulo 41
Clinical Trial Overview of University of Sao Paulo 41
Greenwich Hospital 42
Clinical Trial Overview of Greenwich Hospital 42
Sun Yat-sen University 43
Clinical Trial Overview of Sun Yat-sen University 43
Assistance Publique - Hopitaux de Paris 44
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 44
Five Key Clinical Profiles 45
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 60

List of Tables

Spondylitis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Spondylitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Spondylitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Spondylitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Spondylitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Spondylitis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Spondylitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Spondylitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Spondylitis to Immunology Clinical Trials, G7 Countries (%), 2014* 14
Spondylitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Spondylitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Spondylitis to Immunology Clinical Trials, E7 Countries (%), 2014* 17
Spondylitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Spondylitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Spondylitis Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Spondylitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Spondylitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Spondylitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Spondylitis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Spondylitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Spondylitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Spondylitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Spondylitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Spondylitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough Corporation (Inactive), 2014* 30
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by NuCel, LLC, 2014* 31
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Khorakiwala Holdings and Investments Private Limited, 2014* 32
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hetero Drugs Limited, 2014* 33
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 34
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 35
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Central Council for Research in Homoeopathy, 2014* 36
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Turku University Hospital, 2014* 37
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Singapore General Hospital, 2014* 38
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rehazentrum Bad Eilsen, 2014* 39
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Manipal University, 2014* 40
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014* 41
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Greenwich Hospital, 2014* 42
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 43
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 44

List of Figures

Spondylitis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Spondylitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Spondylitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Spondylitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Spondylitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Proportion of Spondylitis to Immunology Clinical Trials, G7 Countries (%), 2014* 14
Spondylitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Spondylitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Spondylitis to Immunology Clinical Trials, E7 Countries (%), 2014* 17
Spondylitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Spondylitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Spondylitis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Spondylitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Spondylitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Spondylitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Spondylitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Spondylitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Spondylitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Spondylitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Spondylitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 59

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.